Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-03-29

FDA Approved: INVOKANA — Original Application (Janssen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved INVOKANA (canagliflozin) through its original application, establishing this drug as a novel therapy for adults with type 2 diabetes mellitus. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • INVOKANA (CANAGLIFLOZIN)

Snippet

ORIG AP for INVOKANA (CANAGLIFLOZIN)